CORNEAL GRAFT REJECTION side effect
What is CORNEAL GRAFT REJECTION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
CORNEAL GRAFT REJECTION and Recently Reported Side Effects
CORNEAL GRAFT REJECTION and 15 most Active Side Effect polls
CORNEAL GRAFT REJECTION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with CORNEAL GRAFT REJECTION
GENTAMICIN LUCENTIS PREDNISOLONE SANDIMMUNE VIGAMOX XALATANVigamox Side Effects Report #5628853-X
Consumer or non-health professional from UNITED STATES reported VIGAMOX problem on Jan 29, 2008. Female patient was diagnosed with prophylaxis and was treated with VIGAMOX. After drug was administered, patient experienced the following problems/side effects: corneal graft rejection, treatment failure, . VIGAMOX dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, REFRESH, MEDROXYPROGESTERONE, GENTEAL. Patient recovered.
Prednisolone Side Effects Report #5639798-3
PREDNISOLONE ACETATE problem was reported by a Health Professional from UNITED STATES on Feb 25, 2008. Male patient was diagnosed with corneal transplant and was treated with PREDNISOLONE ACETATE. After drug was administered, patient experienced the following problems/side effects: corneal graft rejection, . PREDNISOLONE ACETATE dosage: unknown. Patient recovered.
Xalatan Side Effects Report #5391523-X
Consumer or non-health professional from UNITED STATES reported XALATAN problem on July 09, 2007. Male patient, weighting 220.0 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: corneal graft rejection, ocular hyperaemia, . XALATAN dosage: unknown. During the same period patient was treated with TIMOPTIC, IMIPRAMINE, ATENOLOL. Patient recovered.
Xalatan Side Effects Report #5399498-4
XALATAN problem was reported by a Physician from UNITED STATES on July 17, 2007. Male patient, weighting 220.0 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: corneal graft rejection, corneal oedema, corneal opacity, ocular hyperaemia, . XALATAN dosage: unknown. During the same period patient was treated with TIMOPTIC, IMIPRAMINE, ATENOLOL. Patient recovered.
Xalatan Side Effects Report #5391523-X
Consumer or non-health professional from UNITED STATES reported XALATAN problem on July 09, 2007. Male patient, weighting 220.0 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: corneal graft rejection, ocular hyperaemia, . XALATAN dosage: unknown. During the same period patient was treated with TIMOPTIC, IMIPRAMINE, ATENOLOL. Patient recovered.
Xalatan Side Effects Report #5399498-4
XALATAN problem was reported by a Physician from UNITED STATES on July 17, 2007. Male patient, weighting 220.0 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: corneal graft rejection, corneal oedema, corneal opacity, ocular hyperaemia, . XALATAN dosage: unknown. During the same period patient was treated with TIMOPTIC, IMIPRAMINE, ATENOLOL. Patient recovered.
Lucentis Side Effects Report #5665277-3
Consumer or non-health professional from UNITED STATES reported LUCENTIS problem on Mar 07, 2008. Female patient was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: complications of transplant surgery, corneal graft rejection, visual disturbance, . LUCENTIS dosage: unknown. During the same period patient was treated with ECONOPRED PLUS, RESTASIS. Patient recovered.
Gentamicin Side Effects Report #5777112-3
GENTAMICIN SULPHATE problem was reported by a Physician from AUSTRALIA on May 29, 2008. Female patient, 52 years of age, was diagnosed with keratitis and was treated with GENTAMICIN SULPHATE. After drug was administered, patient experienced the following problems/side effects: cataract, conjunctival hyperaemia, corneal graft rejection, corneal perforation, corneal thinning, corneal transplant, eye infection fungal, flat anterior chamber of eye, . GENTAMICIN SULPHATE dosage: unknown. During the same period patient was treated with FLUOROMETHOLONE, NATAMYCIN, POVIDONE IODINE. Patient recovered.
Sandimmune Side Effects Report #5315398-X
Physician from SLOVENIA reported SANDIMMUNE problem on Apr 26, 2007. Male patient was diagnosed with uveitis and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: bradykinesia, cerebral atrophy, corneal graft rejection, corneal transplant, extrapyramidal disorder, keratitis, muscle rigidity, musculoskeletal stiffness, . SANDIMMUNE dosage: 200 MG, BID. During the same period patient was treated with ULTOP, CACO, MEDROL. Patient was hospitalized and became disabled. Patient recovered.
Sandimmune Side Effects Report #5255091-5
SANDIMMUNE problem was reported by a Physician from SLOVENIA on Feb 21, 2007. Male patient was diagnosed with uveitis and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: bradykinesia, cerebral atrophy, corneal graft rejection, extrapyramidal disorder, keratitis, muscle rigidity, musculoskeletal stiffness, tremor, . SANDIMMUNE dosage: 200 MG, BID. During the same period patient was treated with ULTOP, CACO, MEDROL. Patient recovered.